The pool of hematopoietic stem cells that actively contributes to hematopoiesis is small, and the cells replicate slowly. Patients with paroxysmal nocturnal hemoglobinuria invariably have a mutation in the PIG-A gene, and many have more than one clone of PIG-A mutated cells. Typically there is a dominant clone and a smaller second clone. By using a combination of stochastic dynamics and models of hematopoiesis, we show that it is very unlikely that more than one PIG-A mutated clone arises at the level of the hematopoietic stem cells. More likely, the smaller clone develops in the progenitor cell pool that would be expected to contribute to hematopoiesis for a shorter period of time. We provide estimates for the duration of these contributio...
Paroxysmal nocturnal hemoglobinurea (PNH) is a rare disorder of complement regulation due to somatic...
The purpose of these studies was to determine the molecu-lar basis of the phenotypic mosaicism that ...
(PNH) is caused by phosphatidylinositol glycan–class A (PIG-A) mutations in he-matopoietic stem cell...
The pool of hematopoietic stem cells that actively contributes to hematopoiesis is small, and the ce...
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal blood disorder characterized by hemo...
<div><p>Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal blood disorder characterized...
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal blood disorder characterized by hemo...
Leukemias arise due to mutations in the genome of hematopoietic (blood) cells. Hematopoiesis has a m...
<p><b>A.</b> Likelihood of existence of clones over time. As a test of accuracy, the probabilities f...
Patients with paroxysmal nocturnal hemoglobinuria (PNH) have one or a few clones of mutant hematopoi...
Clonal disease is often regarded as almost synonymous with cancer. However, it is becoming increasin...
BACKGROUND AND OBJECTIVESParoxysmal nocturnal hemoglobinuria (PNH), a clonal hematopoietic stem cell...
Background. Blood cell formation is maintained by the replication of hematopoietic stem cells (HSC) ...
BACKGROUND: Blood cell formation is maintained by the replication of hematopoietic stem cells (HSC) ...
<p><b>A.</b> The size probability distribution for an established clone multiple years after diagnos...
Paroxysmal nocturnal hemoglobinurea (PNH) is a rare disorder of complement regulation due to somatic...
The purpose of these studies was to determine the molecu-lar basis of the phenotypic mosaicism that ...
(PNH) is caused by phosphatidylinositol glycan–class A (PIG-A) mutations in he-matopoietic stem cell...
The pool of hematopoietic stem cells that actively contributes to hematopoiesis is small, and the ce...
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal blood disorder characterized by hemo...
<div><p>Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal blood disorder characterized...
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal blood disorder characterized by hemo...
Leukemias arise due to mutations in the genome of hematopoietic (blood) cells. Hematopoiesis has a m...
<p><b>A.</b> Likelihood of existence of clones over time. As a test of accuracy, the probabilities f...
Patients with paroxysmal nocturnal hemoglobinuria (PNH) have one or a few clones of mutant hematopoi...
Clonal disease is often regarded as almost synonymous with cancer. However, it is becoming increasin...
BACKGROUND AND OBJECTIVESParoxysmal nocturnal hemoglobinuria (PNH), a clonal hematopoietic stem cell...
Background. Blood cell formation is maintained by the replication of hematopoietic stem cells (HSC) ...
BACKGROUND: Blood cell formation is maintained by the replication of hematopoietic stem cells (HSC) ...
<p><b>A.</b> The size probability distribution for an established clone multiple years after diagnos...
Paroxysmal nocturnal hemoglobinurea (PNH) is a rare disorder of complement regulation due to somatic...
The purpose of these studies was to determine the molecu-lar basis of the phenotypic mosaicism that ...
(PNH) is caused by phosphatidylinositol glycan–class A (PIG-A) mutations in he-matopoietic stem cell...